Psycho-Physiological associates of dyspnea in hospitalized patients with interstitial lung diseases: A Cross-Sectional study

International Journal of Environmental Research and Public Health

Volumn 14, Issue 10, 2017, Pages

  Zhou, Yan Hua ^a,b   Mak, Yim Wah ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Anxiety; Cough; Depression; Dyspnea; Interstitial lung diseases; Lung function; Psycho physiological factors; Six minute walk test

Indexed keywords

DISEASE PREVALENCE; MENTAL HEALTH; MORTALITY; PHYSIOLOGY; PSYCHOLOGY; RESPIRATORY DISEASE;

ADULT; ANXIETY; ARTICLE; CHINA; CHINESE; CHRONIC DISEASE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EXERCISE INTENSITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; OBSTRUCTIVE AIRWAY DISEASE; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; PULMONARY REHABILITATION; SIX MINUTE WALK TEST; WORK; AGED; STATISTICAL MODEL;

CHINA; GUANGDONG; GUANGZHOU;

ADULT; AGED; ANXIETY; CHINA; COUGH; CROSS-SECTIONAL STUDIES; DEPRESSION; DYSPNEA; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; MALE; MENTAL HEALTH; MIDDLE AGED; PREVALENCE;

EID: 85032435627     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph14101277     Document Type: Article

References (62)

1. Cosgrove, G.P., Schwarz, M.I. Approach to the evaluation and diagnosis of interstitial lung disease. In Interstitial Lung Disease, 5th ed., Schwarz, M.I., King, T.E., Jr., Eds., PMPH-USA: Shelton, CT, USA, 2011, p. 3.
2. Olson, A.L., Swigris, J.J., Lezotte, D.C., Norris, J.M., Wilson, C.G., Brown, K.K. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am. J. Respir. Crit. Care Med. 2007, 176, 277-283.
3. Kornum, J.B., Christensen, S., Grijota, M., Pedersen, L., Wogelius, P., Beiderbeck, A., Sørensen, H.T. The incidence of interstitial lung disease 1995-2005: A Danish nationwide population-based study. BMC Pulm. Med. 2008, 8, 1-7.
4. Kim, R., Meyer, K.C. Review: Therapies for interstitial lung disease: Past, present and future. Ther. Adv. Respir. Dis. 2008, 2, 319-338.
5. Ryerson, C.J., Cayou, C., Topp, F., Hilling, L., Camp, P.G., Wilcox, P.G., Khalil, N., Collard, H.R., Garvey, C. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study. Respir. Med. 2014, 108, 203-210.
6. Meek, P.M., Schwartzstein, R.M., Adams, L., Altose, M.D., Breslin, E.H., Carrieri-Kohlman, V., Gift, A., Hanley, M.V., Harver, A., Jones, P.W. Mechanisms, assessment, and management: A consensus statement. Am. J. Respir. Crit. Care Med. 1999, 159, 321-340.
7. Nagata, K., Tomii, K., Otsuka, K., Tachikawa, R., Otsuka, K., Takeshita, J., Tanaka, K., Matsumoto, T., Monden, K. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology 2012, 17, 506-512.
8. Sanchez, O., Caumont-Prim, A., Gillet-Juvin, K., Callens, E., Graba, S., Essalhi, M., Chevalier-Bidaud, B., Israel-Biet, D., Mahut, B., Delclaux, C. Activity-related dyspnea is not modified by psychological status in people with COPD, interstitial lung disease or obesity. Respir. Physiol. Neurobiol. 2012, 182, 18-25.
9. Natori, H., Kawayama, T., Suetomo, M., Kinoshita, T., Matsuoka, M., Matsunaga, K., Okamoto, M., Hoshino, T. Evaluation of the modified medical research council dyspnea scale for predicting hospitalization and exacerbation in Japanese patients with chronic obstructive pulmonary disease. Intern. Med. 2016, 55, 15-24.
10. Adams, S., Fan, V., Nguyen, H., Borson, S., Kohen, R., Matute-Bello, G., Pagalilauan, G., Anzueto, A. Clinical outcomes in chronic obstructive pulmonary disease are associated with perception of dyspnea more than exacerbation risk or disease severity measured by lung function. Chest 2012, 142, 676A. [CrossRef]
11. Manali, E.D., Stathopoulos, G.T., Kollintza, A., Kalomenidis, I., Emili, J.M., Sotiropoulou, C., Daniil, Z., Roussos, C., Papiris, S.A. The medical research council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir. Med. 2008, 102, 586-592.
12. Ryerson, C.J., Collard, H.R., Pantilat, S.Z. Management of dyspnea in interstitial lung disease. Curr. Opin. Support. Palliat. Care 2010, 4, 69-75.
13. Coelho, A.C., Knorst, M.M., Gazzana, M.B., Barreto, S.S. Predictors of physical and mental health-related quality of life in patients with interstitial lung disease: A multifactorial analysis. J. Bras. Pneumol. 2010, 36, 562-570.
14. Baddini Martinez, J.A., Martinez, T.Y., LovetroGalhardo, F.P., de Castro Pereira, C.A. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med. Sci. Monit. 2002, 8, CR405-CR410. [PubMed]
15. Chang, J.A., Curtis, J.R., Patrick, D.L., Raghu, G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999, 116, 1175-1182.
16. De Boer, S., Kolbe, J., Wilsher, M.L. The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis. Respirology 2014, 19, 1019-1024.
17. Han, M.K., Swigris, J., Liu, L., Bartholmai, B., Murray, S., Giardino, N., Thompson, B., Frederick, M., Li, D., Schwarz, M., et al. Gender influences health-related quality of life in IPF. Respir. Med. 2010, 104, 724-730.
18. Holland, A.E., Fiore, J.F., Jr., Bell, E.C., Goh, N., Westall, G., Symons, K., Dowman, L., Glaspole, I. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology 2014, 19, 1215-1221.
19. Londner, C., Al Dandachi, G., Plantier, L., Gillet-Juvin, K., Chevalier-Bidaud, B., Mahut, B., Israel-Biet, D., Delclaux, C. Cross-sectional assessment of the relationships between dyspnea domains and lung function in diffuse parenchymal lung disease. Respiration 2014, 87, 105-112.
20. Lubin, M., Chen, H., Elicker, B., Jones, K.D., Collard, H.R., Lee, J.S. A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Chest 2014, 145, 1333-1338.
21. Manali, E.D., Lyberopoulos, P., Triantafillidou, C., Kolilekas, L.F., Sotiropoulou, C., Milic-Emili, J., Roussos, C., Papiris, S.A. MRC chronic dyspnea scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: A prospective study. BMC Pulm. Med. 2010, 10, 32.
22. Mura, M., Ferretti, A., Ferro, O., Zompatori, M., Cavalli, A., Schiavina, M., Fabbri, M. Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis. Respiration 2006, 73, 495-502.
23. Papiris, S.A., Daniil, Z.D., Malagari, K., Kapotsis, G.E., Sotiropoulou, C., Milic-Emili, J., Roussos, C. The medical research council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir. Med. 2005, 99, 755-761.
24. Ryerson, C.J., Berkeley, J., Carrieri-Kohlman, V.L., Pantilat, S.Z., Landefeld, C.S., Collard, H.R. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest 2011, 139, 609-616.
25. Swigris, J.J., Yorke, J., Sprunger, D.B., Swearingen, C., Pincus, T., du Bois, R.M., Brown, K.K., Fischer, A. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. Respir. Med. 2010, 104, 1350-1355.
26. Yorke, J., Swigris, J., Russell, A.M., Moosavi, S.H., Ng Man Kwong, G., Longshaw, M., Jones, P.W. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011, 139, 159-164.
27. Hardie, G.E., Janson, S., Gold, W.M., Carrieri-Kohlman, V., Boushey, H.A. Ethnic differences: Word descriptors used by African-American and white asthma patients during induced bronchoconstriction. Chest 2000, 117, 935-943.
28. Han, J., Zhu, Y., Li, S., Chen, X., Put, C., Van de Woestijne, K.P., Van den Bergh, O. Respiratory complaints in Chinese: Cultural and diagnostic specificities. Chest 2005, 127, 1942-1951.
29. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Joint statement adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002, 165, 277-304.
30. Fletcher, C.M., Elmes, P.C., Fairbairn, A.S., Wood, C.H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J. 1959, 2, 257-266.
31. Asthma Workgroup of Chinese Society of Respiratory Disease (CSRD). The Chinese national guidelines on diagnosis and management of cough (December 2010). Chin. Med. J. 2011, 124, 3207-3219.
32. Zigmond, A.S., Snaith, R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand 1983, 67, 361-370.
33. Zheng, L.L., Wang, Y.L., Li, H.C. Application of hospital anxiety and depression scale in general hospital: An analysis in reliability and validity. Shanghai Arch. Psychiatr. 2003, 15, 264-265. (In Chinese)
34. Li, L., Wang, H.M., Shen, Y. Chinese SF-36 Health Survey: Translation, cultural adaptation, validation, and normalisation. J. Epidemiol. Community Health 2003, 57, 259-263.
35. Ware, J.E., Sherbourne, C.D. The MOS36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care 1992, 30, 473-483.
36. Brazier, J.E., Harper, R., Jones, N.M., O’Cathain, A., Thomas, K.J., Usherwood, T., Westlake, L. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. Br. Med. J. 1992, 305, 160-164. [CrossRef]
37. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002, 166, 111-117.
38. Holland, A.E., Hill, C.J., Conron, M., Munro, P., McDonald, C.F. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008, 63, 549-554.
39. Lin, Y.X., Xu, W.N., Liang, L.R., Pang, B.S., Nie, X.H., Zhang, J., Wang, H., Liu, Y.X., Wang, D.Q., Xu, Z.Y., et al. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Chin. Med. J. 2009, 122, 2939-2944. [PubMed]
40. Gronseth, R., Vollmer, W.M., Hardie, J.A., Olafsdottir, I.S., Lamprecht, B., Buist, A.S., Gnatiuc, L., Gulsvik, A., Johannessen, A., Enright, P. Predictors of dyspnoea prevalence: Results from the BOLD study. Eur. Respir. J. 2014, 43, 1610-1620.
41. Theodore, A.C., Tseng, C.H., Li, N., Elashoff, R.M., Tashkin, D.P. Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: Findings from the scleroderma lung study. Chest 2012, 142, 614-621.
42. Martinez-Moragon, E., Perpina, M., Belloch, A., de Diego, A., Martinez-Frances, M. Determinants of dyspnea in patients with different grades of stable asthma. J. Asthma 2003, 40, 375-382.
43. Dean, B.B., Aguilar, D., Johnson, L.F., McGuigan, J.E., Orr, W.C., Fass, R., Yan, N., Morgenstern, D., Dubois, R.W. Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: Frequency, severity and impact on health-related quality of life. Aliment. Pharmacol. Ther. 2008, 27, 327-337.
44. Pihtili, A., Bingol, Z., Kiyan, E., Cuhadaroglu, C., Issever, H., Gulbaran, Z. Obstructive sleep apnea is common in patients with interstitial lung disease. Sleep Breath. 2013, 17, 1281-1288.
45. Kauffman, K.S., Doede, M., Diaz-Abad, M., Scharf, S.M., Bell-Farrell, W., Rogers, V.E., Geiger-Brown, J. Experience of insomnia, symptom attribution and treatment preferences in individuals with moderate to severe COPD: A qualitative study. Patient Preference Adherence 2014, 8, 1699-1704. [PubMed]
46. Zhao, X.P. Quality of Life and Factors Related to It among Patients with Interstitial Lung Diseases. Master’s Thesis, Peking Union Medical College, Beijing, China, May 2011. (In Chinese)
47. Poh, H., Eastwood, P.R., Cecins, N.M., Ho, K.T., Jenkins, S.C. Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 2006, 11, 211-216.
48. O’Donnell, D.E., Ora, J., Webb, K.A., Laveneziana, P., Jensen, D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir. Physiol. Neurobiol. 2009, 167, 116-132.
49. Waatevik, M., Johannessen, A., Hardie, J.A., Bjordal, J.M., Aukrust, P., Bakke, P.S., Eagan, T.M. Different COPDdisease characteristics are related to different outcomes in the 6-minute walk test. COPD 2012, 9, 227-234.
50. Carrieri-Kohlman, V., Gormley, J.M., Douglas, M.K., Paul, S.M., Stulbarg, M.S. Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching. Chest 1996, 110, 1526-1535.
51. Wang, R., Wu, C., Zhao, Y., Yan, X., Ma, X., Wu, M., Liu, W., Gu, Z., Zhao, J., He, J. Health related quality of life measured by SF-36: A population-based study in Shanghai, China. BMC Public Health 2008, 8, 292.
52. Lacasse, Y., Wong, E., Guyatt, G.H., Cook, D.J., Goldstein, R.S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996, 348, 1115-1119. [CrossRef]
53. Buck, D., Jacoby, A., Baker, G.A., Ley, H., Steen, N. Cross-cultural differences in health-related quality of life of people with epilepsy: Findings from a European study. Qual. Life Res. 1999, 8, 675-685.
54. Alonso, J., Buron, A., Bruffaerts, R., He, Y., Posada-Villa, J., Lepine, J.P., Angermeyer, M.C., Levinson, D., de Girolamo, G., Tachimori, H., et al. Association of perceived stigma and mood and anxiety disorders: Results from the World Mental Health Surveys. Acta Psychiatr. Scand. 2008, 118, 305-314.
55. Peltzer, K., Pengpid, S. Anticipated stigma in chronic illness patients in Cambodia, Myanmar and Vietnam. Nagoya J. Med. Sci. 2016, 78, 423-435. [PubMed]
56. Strang, S., Ekberg-Jansson, A., Henoch, I. Experience of anxiety among patients with severe COPD: A qualitative, in-depth interview study. Palliat. Support. Care 2014, 12, 465-472.
57. Hong, J.S., Tian, J. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support. Care Cancer 2014, 22, 453-459.
58. Xu, W., Collet, J.P., Shapiro, S., Lin, Y., Yang, T., Platt, R.W., Wang, C., Bourbeau, J. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 2008, 178, 913-920.
59. Lou, P., Zhu, Y., Chen, P., Zhang, P., Yu, J., Wang, Y., Chen, N., Zhang, L., Wu, H., Zhao, J. Interaction of depressive and anxiety symptoms on the mortality of patients with COPD: A preliminary study. COPD 2014, 11, 444-450.
60. Ryder, A.G., Yang, J., Zhu, X., Yao, S., Yi, J., Heine, S.J., Bagby, R.M. The cultural shaping of depression: Somatic symptoms in China, psychological symptoms in North America? J. Abnorm. Psychol. 2008, 117, 300-313.
61. Lansing, R.W., Gracely, R.H., Banzett, R.B. The multiple dimensions of dyspnea: Review and hypotheses. Respir. Physiol. Neurobiol. 2009, 167, 53-60.
62. Parshall, M.B., Schwartzstein, R.M., Adams, L., Banzett, R.B., Manning, H.L., Bourbeau, J., Calverley, P.M., Gift, A.G., Harver, A., Lareau, S.C., et al. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am. J. Respir. Crit. Care Med. 2012, 185, 435-452.